Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses.
about
Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa RicaHuman papillomavirus-16 modifies the association between fruit consumption and head and neck squamous cell carcinomaHighly sensitive detection of Staphylococcus aureus directly from patient bloodCross-sectional study of genital carcinogenic HPV infections in Paramaribo, Suriname: prevalence and determinants in an ethnically diverse population of women in a pre-vaccination era.Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection.Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.The usefulness of immunohistochemistry in tissue microarrays of Human Papillomavirus negative adenocarcinoma of the uterine cervix.Human Papillomavirus (HPV) Prevalence in Nasal and Antrochoanal Polyps and Association with Clinical Data.DNA microarray format for detection and subtyping of human papillomavirus.Inter-laboratory validation of PCR-based HPV detection in pathology specimens.Human Papillomavirus type distribution in invasive cervical cancer in UgandaEffect of PCR amplicon size on assessments of clone library microbial diversity and community structureDetection of HPV and the role of p16INK4A overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer.Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from ItalyHuman papillomavirus infection and squamous cell carcinoma of the conjunctiva.Human papillomavirus type distribution and correlation with cyto-histological patterns in women from the South of Italycomparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.Type-specific incidence, clearance and predictors of cervical human papillomavirus infections (HPV) among young women: a prospective study in Uganda.Contemporary theories of cervical carcinogenesis: the virus, the host, and the stem cell.Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay.GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes.Target region selection is a critical determinant of community fingerprints generated by 16S pyrosequencingDevelopment and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirusOne virus, one lesion--individual components of CIN lesions contain a specific HPV type.Sentinel-base DNA genotyping using multiple sequencing primers for high-risk human papillomavirusesDetection and quantitation of HPV in genital and oral tissues and fluids by real time PCR.Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates.Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16.High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil.Comparison of human papillomavirus detection between freshly frozen tissue and paraffin embedded tissue of invasive cervical cancer.High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men.Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections.Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical intraepithelial neoplasia and cervical infection in young Japanese women.HPV genotyping and site of viral integration in cervical cancers in Indian women.Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA.E4 antibodies facilitate detection and type-assignment of active HPV infection in cervical diseaseHuman papillomavirus in cervical cancer.Assessment of human papillomavirus in lung tumor tissueEvaluation of a novel highly sensitive, broad-spectrum PCR-reverse hybridization assay for detection and identification of beta-papillomavirus DNAAssessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests.
P2860
Q21089767-FF83E778-9025-4897-A934-31331BAFA9BCQ23917546-56491B1F-E017-43B4-B4C5-ECA9E697E550Q28732001-6F249F5F-303F-468F-A479-5E2ED48F771FQ29353702-B91845A9-7F5F-472D-AF04-980360E51291Q30354637-7BCDEB37-FCD7-437D-8436-3F7336B764B5Q30970916-9A1D9E26-F3BD-4C83-A922-B7151094DA93Q30978718-A8FEEB3C-E739-49AC-BB94-A4BDC58754B5Q31012345-3411AB73-101F-493F-BB18-2BA76A21C7F6Q31058927-8748F3B4-8407-41F8-B303-BA0371B0B682Q33290324-FEEB7705-AB18-49F9-B71B-641FDADAB4EBQ33346465-14DB80CD-3F84-4A9D-B987-2D4B4D64A7B3Q33409647-744CE66E-0705-400C-ACDE-BA2E43D05DEBQ33546704-C9A4C886-1583-41AB-A732-AB082DE13B63Q33595321-CA694488-05CD-4F59-8819-00D3B23D079CQ33630795-6AF1CD9E-2069-453D-9D0B-DE093AA4B70BQ33633372-ABBA342C-4AEF-4BA1-95C2-237BC5A689D4Q33856287-CC1EA045-D2B2-4CA2-86A2-9772233EEAEBQ33863369-EE6EC894-F63D-41AE-A5C9-CA88B3F9BDA7Q33886737-A278B905-7379-49E0-9D3C-E3597533B468Q33950682-8F592F31-28D0-40AF-827B-FA1F47B30E91Q33950978-27EF7DEB-0C13-4FF5-81DA-DE8A3DF0DB59Q33954647-B54B7DC4-B201-49A2-98CA-574259507D55Q33961947-63238D0B-DBC1-4A58-A21D-C585C8B36EA0Q34086371-D9147203-3522-4D3D-90AA-0C73C5CDDD7DQ34102195-ABF3D62C-ED17-4B6E-9A75-FD246A1C08AAQ34105003-AE407780-AB88-4044-9FF3-3B9F1F3F4F70Q34149348-53902419-2BD0-440F-B2B8-73F8C22E1DDCQ34196510-A011336D-95EE-4C00-8248-3E487ED8F8FBQ34197471-106E8C0F-8BDA-4818-8F88-4C89331084D3Q34198635-5FFCC149-F74E-43AF-8599-FEE66E0CBC8CQ34231736-9973734E-234F-4D10-B9A9-B68D04BFD13FQ34267472-D36E7E27-AAA0-48D2-9FC5-181BA1BA5B67Q34291189-D0F14682-484E-4CE9-AF42-D50E679D0EC9Q34345540-D26485CF-433D-4A4F-96F0-757C215F18FDQ34430779-3D195857-713C-4F77-BFFD-1A31E7B4ED79Q34506439-D60C6AAF-393C-4162-8F2A-5B28CEDC1E2DQ34514132-5957F6D6-1A81-48A2-A086-FC859DF51D6EQ34677186-4E211384-807C-45B5-A425-33FDE9A34A1DQ34680823-0A0B940C-04AF-4EA7-8B8F-D1AEE0BC52BAQ34720093-4E37B94E-38EE-44B5-A413-CB2614C1BD15
P2860
Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Novel short-fragment PCR assay ...... enital human papillomaviruses.
@ast
Novel short-fragment PCR assay ...... enital human papillomaviruses.
@en
type
label
Novel short-fragment PCR assay ...... enital human papillomaviruses.
@ast
Novel short-fragment PCR assay ...... enital human papillomaviruses.
@en
prefLabel
Novel short-fragment PCR assay ...... enital human papillomaviruses.
@ast
Novel short-fragment PCR assay ...... enital human papillomaviruses.
@en
P2093
P2860
P1476
Novel short-fragment PCR assay ...... enital human papillomaviruses.
@en
P2093
B ter Harmsel
J ter Schegget
K van Krimpen
L J van Doorn
L Schrauwen
P2860
P304
P356
10.1016/S0002-9440(10)65688-X
P407
P577
1998-12-01T00:00:00Z